2007
DOI: 10.1001/archderm.143.3.413
|View full text |Cite
|
Sign up to set email alerts
|

Topical Hydrocortisone From Prescription to Over-the-Counter Sale

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 9 publications
0
7
0
Order By: Relevance
“…Some studies estimate the potential impact of the switch on specific therapeutic classes, such as antihistamines, cough and cold preparations, and drugs for acid-related disorders (Temin, 1983 , 1992 ; Sullivan et al, 2005 ; Ravis and Eaglstein, 2007 ). Other authors estimate a more general economic impact of switching drugs from Rx to non-prescription for some therapeutic classes in countries, such as Greece 1 , Spain 2 and France (European Commission., 2015 ).…”
Section: Introductionmentioning
confidence: 99%
“…Some studies estimate the potential impact of the switch on specific therapeutic classes, such as antihistamines, cough and cold preparations, and drugs for acid-related disorders (Temin, 1983 , 1992 ; Sullivan et al, 2005 ; Ravis and Eaglstein, 2007 ). Other authors estimate a more general economic impact of switching drugs from Rx to non-prescription for some therapeutic classes in countries, such as Greece 1 , Spain 2 and France (European Commission., 2015 ).…”
Section: Introductionmentioning
confidence: 99%
“…That is, the risks are higher when consumers of nonprescription drugs deviate from label directions in ways that are associated with increased risk. Importantly, the risks associated with the use of a drug must be evaluated in the context of existing alternatives for the same condition 24 . Furthermore, any incremental benefit–risk analysis is complicated by lack of definitive information about how patients actually use drugs that are accessed with a prescription from a physician.…”
Section: Risk Domains For Nonprescription Drugsmentioning
confidence: 99%
“…Importantly, the risks associated with the use of a drug must be evaluated in the context of existing alternatives for the same condition. 24 Furthermore, any incremental benefit-risk analysis is complicated by lack of definitive information about how patients actually use drugs that are accessed with a prescription from a physician. There is much evidence to suggest that compliance and adherence to prescription directions on the part of consumers are far from perfect, making the comparator for risks in the nonprescription setting less obvious.…”
Section: Risk Domains For Nonprescription Drugs Risks Inherent To a Drugmentioning
confidence: 99%
“…Compound F (hydrocortisone; cortisol) quickly became the first topically applied corticosteroid effective in a variety of inflammatory skin disorders (Sulzberger & Witten 1952, Ravis & Eaglstein 2007. Meanwhile, cortisone was being hailed as a panacea for treating various diseases of unknown cause but with an inflammatory basis.…”
Section: S: Steroid Chemistrymentioning
confidence: 99%